Brief: CSL Ltd And AWS Collaborate To Advance Biopharmaceutical Research And Development
BRIEF-CSL Ltd And AWS Collaborate To Advance Biopharmaceutical Research And Development Sept 29 (Reuters) - CSL Limited CSL.AX:
CSL AND AWS COLLABORATE TO ADVANCE BIOPHARMACEUTICAL RESEARCH AND DEVELOPMENT
COLLABORATION WITH AWS TO APPLY ARTIFICIAL INTELLIGENCE AND CLOUD TECHNOLOGIES TO SUPPORT CO'S RESEARCH & CLINICAL DEVELOPMENT
COLLABORATION WITH AMAZON WEB SERVICES
IN CLINICAL DEVELOPMENT, CSL WORKING WITH AWS TO REDUCE MANUAL EFFORT IN AREAS INCLUDING PROTOCOL AUTHORING, OTHERS
Further company coverage: CSL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CSL
See all newsAustralia's CSL faces investor proceeding over disclosure obligations (updated)
Australia's CSL faces investor proceeding over disclosure obligations
Citi says CSL's CEO pick brings key strengths
Australia's CSL names GSK executive Waterhouse as next CEO (updated)
Brief: CSL Limited Appoints Deborah Waterhouse As CEO And Managing Director